DEVELOPMENTAL FUNDS

描述（由申请人提供）：CCSG的发展基金代表了 核心补助金的最重要组成部分，因为它们允许中心主任回应并领导中心的科学需求和优先事项。 我们以多种方式使用这些资金。 首先，“新研究者”资金与其他中心资金一起使用（例如，礼品帐户）和资金从部门和其他中心提供有吸引力的招聘包教师重要的癌症中心的研究企业。 这些招聘可能代表了一个新的研究计划或现有计划的扩展或替代离职或退休教师的积累。 我们要求将这一类别的经费从每年30万美元增加到每年40万美元，这反映了征聘费用的增加以及受援国在领导和赠款支助方面的出色“回报”。 这些资金的第二个用途是我们的“试点”赠款计划，该计划利用大学范围内的申请程序，重点是年轻或新教师。 我们完全资助3个试点 每年赠款（每笔40，000美元），并在2个独立的年度竞赛中为其他3项（核心赠款-10，000美元和ACS机构赠款-20，000美元）做出贡献。 我们的科学咨询委员会审查并批评这些癌症中心研究优先事项和国家资助潜力的申请。 这些资金的接受者有一个成功的赠款资金（每年直接$390万和超过$1100万过去4年的收件人）和我们的计划的科学增长的良好记录。除上述外，我们还有一项战略，即利用发展基金或核心赠款重新编制发展基金类别的预算，为新的发展共享设施提供资金。 在本资助期内，我们使用从共享设施类别重新预算的资金资助了3个开发共享设施（小动物成像; DNA测序;和分子生物学/重组蛋白）， 以及启动我们的基因表达设施的礼物帐户（设备和启动人员）。

DESCRIPTION (provided by applicant): The Developmental Funds of the CCSG represent one of the most important components of the Core grant in that they allow the Center director to respond to and provide leadership for the scientific needs and priorities of the Center. We use these funds in several ways. First, "New Investigator" funds are used together with other Center funds (e.g., gift account) and funds from departments and other Centers to provide attractive recruitment packages for faculty important to the Cancer Center's research enterprise. These recruitments may represent a build-up for a new research initiative or expansion of an existing program or replacement for departing or retiring faculty. We have asked for an increase in this category from $300,000/year to $400,000/year reflecting the increasing costs of recruitment and the excellent "return" in terms of leadership and grant support by recipients. The second use of these funds is for our "pilot" grant program which utilizes a University-wide application process with an emphasis on young or new faculty. We fully fund 3 pilot grants annually ($40,000 each) and contribute to 3 other (Core grant - $10,000 and ACS institutional grant - $20,000) in 2 separate annual competitions. Our Scientific Advisory Committee reviews and critiques these applications for Cancer Center research priorities and potential for national funding. The recipients of these funds have an excellent track record of successful grant funding (annual direct of $3.9 million and over $11 million for recipients of the past 4 years) and scientific growth of our programs. In addition to the above, we also have a strategy of funding new developmental shared facilities using developmental funds or Core grant re-budgeting to the developmental fund category. This funding period we funded 3 developmental shared facilities (Small Animal Imaging; DNA Sequencing; and Molecular Biology/Recombinant Protein) using funds re-budgeted from the Shared Facility category as well as initiating our Gene Expression facility out of the gift account (equipment and start-up personnel).